Skip to main content

FDA recall, , Moderate risk

Gulf Coast Regional Blood Center Red Blood Cells and Pooled Cryoprecipitated AHF

Red blood cells and pooled cryoprecipitated AHF may have been prepared incorrectly.

Recall ended Jun 8, 2026. Still check yours.

What happened

Gulf Coast Regional Blood Center began a recall on July 17, 2025, of Pooled Cryoprecipitated AHF, Red Blood Cells, Leukocytes Reduced, and Apheresis Red Blood Cells, Leukocytes Reduced, because arm preparation may have been performed incorrectly. The products were distributed in California and Texas. The FDA added the recall to its Enforcement Report and classified it on June 8, 2026.

2 photos

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

3 products

Compare these details with yours, then check the recall notice to see which units are recalled.

  1. Red Blood Cells, Leukocytes Reduced

    Reason: Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.

  2. Pooled Cryoprecipitated AHF

    Reason: Pooled Cryoprecipitated AHF, for which arm preparation may have been performed incorrectly, were distributed.

  3. Apheresis Red Blood Cells, Leukocytes Reduced

    Reason: Apheresis Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.

Recall details

Company began the recall
Company
Gulf Coast Regional Blood Center
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98749
Recall numbers
B-0067-2026 to B-0069-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA · Recall ended

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Archived

Summary by Recall Canary, written with AI · summary updated Oct 24, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)